Upstream Biotechnology is a North Carolina-based agtech company developing RNA-based gene expression solutions to enhance crop disease resistance and resilience, aiming to increase sustainable yields and reduce pesticide dependence for growers.
Upstream Biotechnology, Inc. is an agtech company based in Durham, North Carolina, focused on enhancing crop resilience and sustainability through advanced plant biotechnology. The company has developed a proprietary gene expression platform, including its SwitchBlade technology, which utilizes RNA switches to monitor environmental stress and activate a plant's natural defense mechanisms on-demand. By creating these sophisticated trait solutions, Upstream aims to provide broad-spectrum disease resistance in major crops, such as soybeans and rice, while eliminating the need for excessive chemical pesticide applications and mitigating yield drag associated with traditional stress responses.
This technology is significant for the agricultural sector as it addresses the growing global demand for food security, climate-smart farming, and sustainability. By enabling crops to protect themselves from diverse pathogens and abiotic stresses, Upstream helps growers maintain reliable, high-quality yields in a changing climate. The company actively engages in strategic partnerships, such as its collaboration with Bene Seeds to develop disease-resistant heirloom tomato varieties, and participates in innovation programs like AgLaunch365 to validate and scale its seed-based solutions for broader commercial application.